Peptidyl-dipeptidase A/angiotensin I-converting enzyme

Handbook of Proteolytic Enzymes, Second Edition: Volume 1: Aspartic and Metallo Peptidases

Volumn 1, Issue , 2004, Pages 332-346

  Corvol, Pierre ^a   Eyries, Mélanie ^b   Soubrier, Florent ^b  

^a l'alimentation et l'Environnement   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944073735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-079611-3.50090-2     Document Type: Chapter

References (153)

1. M. Alfalah, E.T. Parkin, R. Jacob, E.D. Sturrock, R. Mentele, A.J. Turner, N.M. Hooper and H.Y. Naim (2001) A point mutation in the juxtamembrane stalk of human angiotensin I-converting enzyme invokes the action of a distinct secretase. J. Biol. Chem. 276 21105-21109.
2. M. Azizi, A. Rousseau, E. Ezan, T.-T. Guyene, S. Michelet, J.-M Grognet, M. Lenfant, P. Corvol and J. Ménard (1996) Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J. Clin. Invest. 97 839-844.
3. M. Azizi, E. Ezan, L. Nicolet, J.M. Grognet and J. Ménard (1997) High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 30 1015-1019.
4. M. Azizi, E. Ezan, J.L. Reny, J. Wdzieczak-Bakala, V. Gerineau and J. Ménard (1999) Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans. Hypertension 33 879-886.
5. K. Barnes, R. Matsas, N.M. Hooper, A.J. Turner and A.J. Kenny (1988) Endopeptidase 24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and dipeptidyl dipeptidase, an angiotensin converting enzyme, is a marker for a set of striatal efferent fibers. Neuroscience 27 799-817.
6. V. Beldent, A. Michaud, L. Wei, M.-T. Chauvet and P. Corvol (1993) Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J. Biol. Chem. 268 26428-26433.
7. V. Beldent, A. Michaud, C. Bonnefoy, M.-T. Chauvet and P. Corvol (1995) Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. J. Biol. Chem. 270 28962-28969.
8. T. Berg, J. Sulner, C.Y. Lai and R.L. Soffer (1986) Immunohistochemical localization of two angiotensin I-converting isoenzymes in the reproductive tract of the male rabbit. J. Histochem. Cytochem. 34 753-760.
9. K.E. Bernstein, B.M. Martin, A.S. Edwards and E.A. Bernstein (1989) Mouse angiotensin I-converting enzyme is a protein composed of two homologous domains. J. Biol. Chem. 264 11945-11951.
10. R.A. Black, C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, M.F. Wolfson, B.J. Castner, K.L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K.A. Schooley, M. Gerhart, R. Davis, J.N. Fitzner, R.S. Johnson, R.J. Paxton, C.J. March and D.P. Cerretti (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 729-733.
11. J.R. Brentjens, S. Matsuo, G.A. Andres, P.R.B. Caldwell and L. Zamboni (1986) Gametes contain angiotensin converting enzyme (kininase II). Experientia 42 399-402.
12. P. Bruneval, N. Hinglais, F. Alhenc-Gelas, V. Tricottet, P. Corvol, J. Ménard, J.-P. Camilleri and J. Bariety (1986) Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry 85 73-80.
13. P. Bünning and J.F. Riordan (1983) Activation of angiotensin converting enzyme by monovalent anions. Biochemistry 22 110-116.
14. P. Bünning and J.F. Riordan (1985) The functional role of zinc in angiotensin converting enzyme. Implication for the enzyme mechanism. J. Inorg. Biochem. 24 183-198.
15. P. Bünning, S.G. Kleemann and J.F. Riordan (1990) Essential residues in angiotensin converting enzyme: modification with 1-fluoro-2,4-dinitrobenzene. Biochemistry 29 10488-10492.
16. F. Cambien, F. Alhenc-Gelas, B. Herbeth, J.L. Andre, R. Rakotovao, M.F. Gonzales, J. Allegrini and C. Bloch (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 43 774-780.
17. M. Challah, E. Villard, M. Philippe, A. Ribadeau-Dumas, B. Giraudeau, P. Janiak, J.P. Vilaine, F. Soubrier and J.B. Michel (1998) Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. Arterioscler. Thromb. Vasc. Biol. 18 235-243.
18. Y.N.P. Chen and J.F. Riordan (1990) Identification of essential tyrosine and lysine residues in angiotensin converting enzyme: Evidence for a single active site. Biochemistry 29 10493-10498.
19. Y.N.P. Chen, M.R.W. Ehlers and J.F. Riordan (1992) The functional role of tyrosine-200 in human testis angiotensin-converting enzyme. Biochem. Biophys. Res. Commun. 184 306-309.
20. D. Coates, R.E. Isaac, J. Cotton, R. Siviter, T.A. Williams, A. Shirras, P. Corvol and V. Dive (2000) Functional conservation of the active sites of human and Drosophila angiotension I-converting enzyme. Biochemistry 39 8963-8969.
21. P.M. Colman, J.N. Hansonius and B.W. Matthews (1972) The structure of thermolysin: an electron density map at 2.3 Å resolution. J. Mol. Biol. 70 701-724.
22. M.J. Cornell, T.A. Williams, N.S. Lamango, D. Coates, P. Corvol, F. Soubrier, J. Hoheisel, H. Lehrach and R.E. Isaac (1995) Cloning and expression of an evolutionary conserved single-domain angiotensin converting enzyme from Drosophila melanogaster. J. Biol. Chem. 270 13613-13619.
23. O. Costerousse, J. Allegrini, M. Lopez and F. Alhenc-Gelas (1993) Angiotensin I-converting enzyme in human circulatory mononuclear cells. Genetic polymorphism in T-lymphocytes. Biochem. J. 290 33-40.
24. J. Cotton, M. Hayashi, P. Cuniasse, G. Vazeux, D. Ianzer, A.C. De Carmargo and V. Dive (2002) Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry 41 6065-6071.
25. F. Coulet, W. Gonzalez, C. Boixel, O. Meilhac, M.E. Pueyo and J.B. Michel (2001) Endothelium-independent conversion of angiotensin I by vascular smooth muscle cells. Cell Tissue Res. 303 227-234.
26. M.A. Crackower, R. Sarao, G.Y. Oudit, C. Yagil, I. Kozieradzki, S.E. Scanga, A.J. Oliveira-dos-Santos, J. da Costa, L. Zhang, Y. Pei, J. Scholey, C.M. Ferrario, A.S. Manoukian, M.C. Chappell, P.H. Backx, Y. Yagil and J.M. Penninger (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 822-828.
27. A.H. Danser, M.A. Schalekamp, W.A. Bax, A.M. van den Brink, P.R. Saxena, G.A. Riegger and H. Schunkert (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92 1387-1388.
28. M. Das, J.L. Hartley and R.L. Soffer (1977) Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme. J. Biol. Chem. 252 1316-1319.
29. Y. Dasarathy and B.L. Fanburg (1991) Involvement of second messenger systems in stimulation of angiotensin converting enzyme of bovine endothelial cells. J. Cell. Physiol. 148 327-335.
30. P.A. Deddish, J. Wang, B. Michel, P.W. Morris, N.O. Davidson, R.A. Skidgel and E.G. Erdös (1994) Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc. Natl. Acad. Sci. USA 91 7807-7811.
31. P.A. Deddish, B. Marcic, H.L. Jackman, H.Z. Wang, R.A. Skidgel and E.G. Erdös (1998) N-domain specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1–7) and keto-ACE. Hypertension 31 912-917.
32. R. Defendini, E.A. Zimmerman, J.A. Weare, F. Alhenc-Gelas and E.G. Erdös (1983) Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 37 32-40.
33. V. Dive, J. Cotton, A. Yiotakis, A. Michaud, S. Vassiliou, J. Jiracek, G. Vazeux, M.T. Chauvet, P. Cuniasse and P. Corvol (1999) RXP407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proc. Natl. Acad. Sci. USA 96 4330-4335.
34. M. Donoghue, F. Hsieh, E. Baronas, K. Godbout, M. Gosselin, N. Stagliano, M. Donovan, B. Woolf, K. Robison, R. Jeyaseelan, R.E. Breitbart and S. Acton (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 87 E1-E9.
35. F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine and L.T. Skeggs (1974) Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ. Res. 34 824-827.
36. P. Dubreuil, P. Fulcrand, M. Rodriguez, H. Fulcrand, J. Laur and J. Martinez (1989) Novel activity of angiotensin-converting enzyme hydrolysis of cholecystokinin and gastrin analogues with release of the amidated carboxy-terminal dipeptide. Biochem. J. 262 125-130.
37. M.R.W. Ehlers and R.E. Kirsch (1988) Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pH. Biochemistry 27 5538-5544.
38. M.R.W. Ehlers and J.F. Riordan (1989) Angiotensin-converting enzyme: New concepts concerning its biological role. Biochemistry 28 5311-5318.
39. M.R.W. Ehlers and J.F. Riordan (1990) Angiotensin-converting enzyme. Biochemistry and molecular biology. J.H. Laragh, B.M. Brenner (Eds) Hypertension Pathophysiology, Diagnosis and Management New York: Raven Press 1217-1231.
40. M.R.W. Ehlers and J.F. Riordan (1991) Angiotensin-converting enzyme: zinc- and inhibitor binding stoichiometries of the somatic and testis isozymes. Biochemistry 30 7118-7126.
41. M.R.W. Ehlers, E.A. Fox, D.J. Strydom and J.F. Riordan (1989) Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. USA 86 7741-7745.
42. M.R.W. Ehlers, Y.N.P. Chen and J.F. Riordan (1991) Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 88 1009-1013.
43. M.R.W. Ehlers, Y.N.P. Chen and J.F. Riordan (1992) The unique N-terminal sequence of testis angiotensin-converting enzyme is heavily O-glycosylated and unessential for activity or stability. Biochem. Biophys. Res. Commun. 183 199-205.
44. M.R.W. Ehlers, S.L. Schwager, R.R. Scholle, G.A. Manji, W.F. Brandt and J.F. Riordan (1996) Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry 35 9549-9559.
45. H. El-Dorry, K. Iwata, N.A. Thornberg, E.H. Cordes and R.L. Soffer (1982) Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase. J. Biol. Chem. 257 14128-14133.
46. H.A. El-Dorry, J.S. MacGregor and R.L. Soffer (1983) Dipeptidyl carboxypeptidase from seminal fluid resembles the pulmonary rather than the testicular isoenzyme. Biochem. Biophys. Res. Commun. 115 1096-1100.
47. E.G. Erdös and R.A. Skidgel (1987) The angiotensin I-converting enzyme. Lab. Invest. 56 345-348.
48. C.R. Esther, T.E. Howard, E.M. Marino, J.M. Goddard, M.R. Capecchi and K.E. Bernstein (1996) Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab. Invest. 74 953-965.
49. M. Eyries, A. Michaud, J. Deinum, M. Agrapart, J. Chomilier, C. Kramers and F. Soubrier (2001) Increased shedding of angiotensin-converting enzyme by a mutation identified in the stalk region. J. Biol. Chem. 276 5525-5532.
50. M. Farrall, B. Keavney, C. McKenzie, M. Delepine, F. Matsuda and G.M. Lathrop (1999) Fine-mapping of an ancestral recombination breakpoint in DCP1. Nature Genet. 23 270-271.
51. M. Fernandez, X. Liu, M.A. Wouters, S. Heyberger and A. Husain (2001) Angiotensin I-converting enzyme transition state stabilization by His1089. J. Biol. Chem. 276 4998-5004.
52. R.S. Fishel, S. Eisenberg, S.Y. Shai, R.A. Redden, K.E. Bernstein and B.C. Berk (1995) Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 25 343-349.
53. J. Friedland, C. Setton and E. Silverstein (1978) Induction of angiotensin-converting enzyme in human monocytes in culture. Biochem. Biophys. Res. Commun. 83 843-849.
54. S.J. Gardell, D. Hilvert, J. Barnett, E.T. Kaiser and W.J. Ruter (1987) Use of directed mutagenesis to probe the role of tyrosine 198 in the catalytic mechanism of carboxypeptidase A. J. Biol. Chem. 262 576-582.
55. W. Gosgnach, M. Challah, F. Coulet, J.B. Michel and T. Battle (2000) Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. Cardiovasc. Res. 45 486-492.
56. J.R. Hagaman, J.S. Moyer, E.S. Bachman, M. Sibony, P.L. Magyar, J.E. Welch, O. Smithies, J.H. Krege and D.A. O'Brien (1998) Angiotensin-converting enzyme and male fertility. Proc. Natl. Acad. Sci. USA 95 2552-2557.
57. N.M. Hooper (1991) Angiotensin converting enzyme. Implications from molecular biology for its physiological functions. Int. J. Biochem. 23 611-647.
58. N.M. Hooper and A.J. Turner (1987) Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin-converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism. Biochem. J. 241 625-633.
59. N.M. Hooper, J. Keen, D.J.C. Pappin and A.J. Turner (1987) Pig kidney angiotensin-converting enzyme. Purification and characterization of amphiphatic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem. J. 247 85-93.
60. X. Houard, T.A. Williams, A. Michaud, P. Dani, R.E. Isaac, A.D. Shirras, D. Coates and P. Corvol (1998) The Drosophila melanogaster-related angiotensin I-converting enzymes Acer and Ance distinct enzymic characteristics and alternative expression during pupal development. Eur. J. Biochem. 257 599-606.
61. T.E. Howard, S.Y. Shai, K.G. Langford, B.M. Martin and K.E. Bernstein (1990) Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol. Cell. Biol. 10 4294-4302.
62. T. Howard, R. Balogh, P. Overbeek and K.E. Bernstein (1993) Sperm-specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91-base-pair promoter containing a CRE-like element. Mol. Cell. Biol. 13 1-27.
63. J. Hu, A. Igarashi, M. Kamata and H. Nakagawa (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ); retard Aβ aggregation, deposition, fibril formation and inhibits cytotoxicity. J. Biol. Chem. 276 47863-47868.
64. C. Hubert, A.-M. Houot, P. Corvol and F. Soubrier (1991) Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem. 266 15377-15383.
65. R. Igic, E.G. Erdös, H.S.G. Yen, K. Sorrells and T. Nakajima (1972) Angiotensin I converting enzyme of the lung. Circ. Res. 31(suppl 2), 51-61.
66. J.J. Inokuchi and A. Nagamatsu (1981) Tripeptidyl carboxypeptidase activity of kininase II (angiotensin converting enzyme). Biochim. Biophys. Acta 662 300-307.
67. R.E. Isaac, T.A. Williams, M. Sajid, P. Corvol and D. Coates (1997) Cleavage of arginyl-arginine from the C-terminus of prohormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE. Biochem. J. 328 587-591.
68. R.E. Isaac, A. Michaud, J.N. Keen, T.A. Williams, D. Coates, W.C. Wetsel and P. Corvol (1999) Hydrolysis by somatic angiotensin I-converting enzyme of basic dipeptides from a cholecystokinin/gastrin and a LH-RH peptide extended at the C-terminus with gly-Arg/Lys-arg, but not from diarginyl insulin. Eur. J. Biochem. 262 569-574.
69. E. Jaspard, L. Wei and F. Alhenc-Gelas (1993) Differences in properties and enzymatic specificities between the two active sites of angiotensin I-converting enzyme. Studies with bradykinin and other natural peptides. J. Biol. Chem. 268 9496-9503.
70. C. Junot, J. Ménard, M.F. Gonzales, A. Michaud, P. Corvol and E. Ezan (1999) In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis. J. Pharmacol. Exp. Ther. 289 1257-1261.
71. C. Junot, M.F. Gonzales, E. Ezan, J. Cotton, G. Vazeux, A. Michaud, M. Azizi, S. Vassiliou, A. Yiotakis, P. Corvol and V. Dive (2001) RXP407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis. J. Pharmacol. Exp. Ther. 297 606-611.
72. H. Kawaguchi, H. Sawa, K. Iizuka and H. Yasuda (1990) Platelet-activating factor stimulates angiotensin converting enzyme activity. J. Hypertens. 8 173-177.
73. S.P. Kessler, T.M. Rowe, J.A. Blendy, R.P. Erickson and G.C. Sen (1998) A cyclic AMP response element in the angiotensin-converting enzyme gene and the transcription factor CREM are required for transcription of the mRNA for the testicular isozyme. J. Biol. Chem. 273 9971-9975.
74. S.P. Kessler, T.M. Rowe, J.B. Gomos, P.M. Kessler and G.C. Sen (2000) Physiological non-equivalence of the two isoforms of angiotensin-converting enzyme. J. Biol. Chem. 275 26259-26264.
75. S.P. Kessler, J.B. Gomos, T.S. Scheidemantel, T.M. Rowe, H.L. Smith and G.C. Sen (2002) The germinal isozyme of angiotensin-converting enzyme can substitute for the somatic isozyme in maintaining normal renal structure and functions. J. Biol. Chem. 277 4271-4276.
76. W.R. Kester and B.W. Matthews (1977) Crystallographic study of the binding of dipeptide inhibitors to thermolysin: Implications for the mechanism of catalysis. Biochemistry 16 2506-2516.
77. H.M. Kim, D.R. Shin, O.J. Yoo, H. Lee and J.O. Lee (2003) Crystal structure of Drosophila angiotension I-converting enzyme bound to captopril and lisinopril. FEBS Lett. 538 65-70.
78. S.J. King, F.M. Booyse, P.H. Lin, M. Traylor, A.J. Narkates and S. Oparil (1989) Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis. Am. J. Physiol. 256 C1231-C1238.
79. G. Koike, J.E. Krieger, H.J. Jacob, M. Mukoyama, R.E. Pratt and V.J. Dzau (1994) Angiotensin-converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme. Biochem. Biophys. Res. Commun. 198 380-386.
80. J.H. Krege, S.W.M. John, L.L. Laugenbach, J.B. Hodgin, J.R. Hagaman, E.S. Bachman, J.C. Jennette, D.A. O'Brien and O. Smithies (1995) Male-female differences infertility and blood pressure in ACE-deficient mice. Nature 375 146-148.
81. A.H. Krulewitz, W.E. Baur and B.L. Fanburg (1984) Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am. J. Physiol. 247 C163-C168.
82. R.S. Kumar, J. Kusari, S.N. Roy, R.L. Soffer and G.C. Sen (1989) Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme. J. Biol. Chem. 264 16754-16758.
83. R.S. Kumar, T.J. Thekkumkara and G. Sen (1991) The mRNAs encoding the two angiotensin-converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites. J. Biol. Chem. 266 3854-3862.
84. N. Lamango and R.E. Isaac (1993) Identification of an ACE-like peptidyl dipeptidase activity in the housefly, Musca domestica. Biochem. Soc. Trans. 21 245S.
85. K.G. Langford, S.Y. Shai, T.E. Howard, M.J. Kovac, P.A. Overbeek and K.E. Bernstein (1991) Transgenic mice demonstrate a testis-specific promoter for angiotensin-converting enzyme. J. Biol. Chem. 266 15559-15562.
86. A.L. Lattion, F. Soubrier, J. Allegrini, C. Hubert, P. Corvol and F. Alhenc-Gelas (1989) The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252 99-104.
87. H. LeMoual, A. Devault, B.P. Roques, P. Crine and G. Boileau (1991) Identification of glutamic acid 616 as a zinc-coordinating residue in endopeptidase 24.11. J. Biol. Chem. 266 15670-15674.
88. X. Liu, M. Fernandez, M.A. Wouters, S. Heyberger and A. Husain (2001) Arg1098is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity. J. Biol. Chem. 276 33518-33525.
89. J. Ménard and A.A. Patchett (2001) Angiotensin-converting enzyme inhibitors. Adv. Protein Chem. 56 13-75.
90. F.A. Mendelsohn, C.J. Lloyd, C. Kachel and J.W. Funder (1982) Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. J. Clin. Invest. 70 684-692.
91. A. Michaud, T.A. Williams, M.T. Chauvet and P. Corvol (1997) Substrate dependence of angiotensin-I converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Mol. Pharmacol. 51 1070-1076.
92. A. Michaud, M.T. Chauvet and P. Corvol (1999) N-domain selectivity of angiotensin I-converting enzyme as assessed by structure function studies of its highly selective substrate, N-acetyl-seryl-aspartyl-lysyl-proline. Biochem. Pharmacol. 57 611-618.
93. M.L. Moss, S.L.C. Jin, M.E. Milla, W. Burkhart, H.L. Carter, W.J. Chen, W.C. Clay, J.R. Didsbury, D. Hassler, C.R. Hoffman, T.A. Kost, M.H. Lambert, M.A. Leesnitzer, P. McCauley, G. McGeehan, J. Mitchell, M. Moyer, G. Pahel, W. Rocque, L.K. Overton, F. Schoenen, T. Seaton, J.L. Su and J. Warner (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385 733-736.
94. R. Natesh, S.L. Schwager, E.D. Sturrock and K.R. Acharya (2003) Crystal structure of the human angiotension-converting enzyme-lisinopril complex. Nature 421 551-554.
95. K.K.F. Ng and J.R. Vane (1967) Conversion of angiotensin I to angiotensin II. Nature 216 762-766.
96. K.K.F. Ng and J.R. Vane (1968) Fate of angiotensin I in the circulation. Nature 218 144-150.
97. S. Oparil and E. Haber (1974) The renin angiotensin system. N. Engl. J. Med. 291 389-401.
98. S. Oparil and E. Haber (1974) The renin angiotensin system. N. Engl. J. Med. 291 446-457.
99. S.Y. Oppong and N.M. Hooper (1993) Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem. J. 292 597-603.
100. A. Papapetropoulos, A. Antonov, R. Virmani, F.D. Kolodgie, D.H. Munn, N. Marczin, J.W. Ryan, R.G. Gerrity and J.D. Catravas (1996) Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cells. Circ. Res. 79 512-523.
101. S. Parvathy, S.Y. Oppong, E.H. Karran, D.R. Buckle, A.J. Turner and N.M. Hooper (1997) Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer. Biochem. J. 327 37-43.
102. A.A. Patchett and E.H. Cordes (1985) The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin converting enzyme. Adv. Enzymol. 57 1-84.
103. R.B. Perich, B. Jackson, F. Rogerson, F.A.O. Mendelsohn, D. Paxton and C.I. Johnston (1992) Two binding sites on angiotensin-converting enzyme: Evidence from radioligand binding studies. Mol. Pharmacol. 42 286-293.
104. P. Ramaraj, S.P. Kessler, C. Colmenares and G.C. Sen (1998) Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme. J. Clin. Invest. 102 371-378.
105. R. Ramchandran and I. Sen (1995) Cleavage processing of angiotensin-converting enzyme by a membrane-associated metalloprotease. Biochemistry 34 12645-12652.
106. R. Ramchandran, G.C. Sen, K. Misono and I. Sen (1994) Regulated cleavage-secretion of the membrane-bound angiotensin-converting enzyme. J. Biol. Chem. 269 2125-2130.
107. K.J. Rieger, N. Saez-Servent, M.P. Papet, J. Wdzieczak-Bakala, J.L. Morgat, J. Thierry, W. Woelter and M. Lenfant (1993) Involvements of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide N-acetyl-Seryl-Aspartyl-Lysyl-Proline. Biochem. J. 296 373-378.
108. A. Rousseau, A. Michaud, M.-T. Chauvet, M. Lenfant and P. Corvol (1995) The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270 3656-3661.
109. R. Sadhukhan, G.C. Sen, R. Ramchandran and I. Sen (1998) The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc. Natl. Acad. Sci. USA 95 138-143.
110. R. Sadhukhan, K.R. Santhamma, P. Reddy, J.J. Peschon, R.A. Black and I. Sen (1999) Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice. J. Biol. Chem. 274 10511-10516.
111. O. Saijonmaa, T. Nyman, R. Kosonen and F. Fyhrquist (2001) Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am. J. Physiol. 280 H885-H891.
112. K.R. Santhamma and I. Sen (2000) Specific cellular proteins associate with angiotensin-converting enzyme and regulate its intracellular transport and cleavage-secretion. J. Biol. Chem. 275 23253-23258.
113. H. Schunkert, J.R. Ingelfinger, A.T. Hirsch, Y. Pinto, W.J. Remme, H. Jacob and V.J. Dzau (1993) Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ. Res. 72 312-318.
114. S.L. Schwager, A.J. Chubb, R.R. Scholle, W.F. Brandt, R. Mentele, J.F. Riordan, E.D. Sturrock and M.R. Ehlers (1999) Modulation of juxtamembrane cleavage (‘shedding’) of angiotensin-converting enzyme by stalk glycosylation: evidence for an alternative shedding protease. Biochemistry 38 10388-10397.
115. S.L. Schwager, A.J. Chubb, Z.L. Woodman, L. Yan, R. Mentele, M.R. Ehlers and E.D. Sturrock (2001) Cleavage of disulfide-bridged stalk domains during shedding of angiotensin-converting enzyme occurs at multiple juxtamembrane sites. Biochemistry 40 15624-15630.
116. H. Schweisfurth and S. Schioberg-Schiegnitz (1984) Assay and biochemical characterization of angiotensin I-converting enzyme in cerebrospinal fluid. Enzyme 32 12-19.
117. I. Sen, S. Kasturi, M.A. Jabbar and G.C. Sen (1993) Mutations in two specific residues of testicular angiotensin-converting enzyme change its catalytic properties. J. Biol. Chem. 268 25748-25754.
118. S.Y. Shai, R.S. Fishel, B.M. Martin, B.C. Berk and K.B. Bernstein (1992) Bovine angiotensin converting enzyme cDNA cloning and regulation. Increased expression during endothelial cell growth arrest. Circ. Res. 70 1274-1281.
119. R. Shapiro, B. Holmquist and J.F. Riordan (1983) Anion activation of angiotensin-converting enzyme: dependence on nature of substrate. Biochemistry 22 3850-3857.
120. M. Sibony, D. Segretain and J.-M. Gasc (1994) Angiotensin-converting enzyme in murine testis: Step-specific expression of the germinal isoform during spermiogenesis. Biol. Reprod. 50 1015-1026.
121. L.T. Skeggs, J.R. Kahn and N.P. Shumway (1956) The preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103 295-299.
122. R.A. Skidgel and E.G. Erdös (1985) Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 82 1025-1029.
123. R.A. Skidgel and E.G. Erdös (1987) The broad substrate specificity of human angiotensin I converting enzyme. Clin. Exp. Hypertens. A9 243-259.
124. R.A. Skidgel, S. Engelbrecht, A.R. Johnson and E.G. Erdös (1984) Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5 769-776.
125. F. Soubrier, F. Alhenc-Gelas, C. Hubert, J. Allegrini, M. John, G. Tregear and P. Corvol (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA 85 9386-9390.
126. F. Soubrier, S. Martin, A. Alonso, S. Visvikis, L. Tiret, F. Matsuda, G.M. Lathrop and M. Farrall (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur. J. Hum. Genet. 10 553-561.
127. S.M. Strittmatter and S.H. Snyder (1987) Angiotensin-converting enzyme immuno-histochemistry in rat brain and pituitary gland: correlation of isozyme type with cellular localization. Neuroscience 21 407-420.
128. S.M. Strittmatter, M.M.S. Lo, J.A. Javitch and S.H. Snyder (1984) Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3 H]captopril: localization to a striatonigral pathway. Proc. Natl. Acad. Sci. USA 81 1599-1603.
129. S.M. Strittmatter, E.A. Thiele, M.S. Kapiloff and S.H. Snyder (1985) A rat brain isozyme of angiotensin-converting enzyme. J. Biol. Chem. 260 9825-9832.
130. E.D. Sturrock, C. Yu, Z. Wu, K. Biemann and J.F. Riordan (1996) Assignment of free and disulfide-bonded cysteine residues in testis angiotensin-converting enzyme: Functional implications. Biochemistry 35 9560-9566.
131. P. Testut, P. Corvol and C. Hubert (1993) Functional analysis of the somatic angiotensin I converting enzyme promoter. Biochem. J. 293 843-848.
132. T.J. Thekkumkara, I.W. Livingston, R.S. Kumar and G.C. Sen (1992) Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs. Nucleic Acids. Res. 20 683-687.
133. S.R. Tipnis, N.M. Hooper, R. Hyde, E. Karran, G. Christie and A.J. Turner (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275 33238-33243.
134. O. Traub, B.P. Monia, N.M. Dean and B.C. Berk (1997) PKC-ε is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J. Biol. Chem. 272 31251-31257.
135. A.J. Turner and N.M. Hooper (2002) The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 23 177-183.
136. A.J. Turner, S.R. Tipnis, J.L. Guy, G. Rice and N.M. Hooper (2002) ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can. J. Physiol. Pharmacol. 80 346-353.
137. B.L. Vallee and D.S. Auld (1990) Active-site zinc-ligands and activated H2 O of zinc enzymes. Proc. Natl. Acad. Sci. USA 87 220-224.
138. P.A. Velletri (1985) Testicular angiotensin I-converting enzyme (E.C. 3.4.15.1). Life Sci. 36 1597-1608.
139. E. Villard, L. Tiret, S. Visvikis, R. Rakotovao, F. Cambien and F. Soubrier (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am. J. Hum. Genet. 58 1268-1278.
140. E. Villard, A. Alonso, M. Agrapart, M. Challah and F. Soubrier (1998) Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial cells. J. Biol. Chem. 273 25191-25197.
141. L. Wei, F. Alhenc-Gelas, P. Corvol and E. Clauser (1991) The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266 9002-9008.
142. L. Wei, F. Alhenc-Gelas, F. Soubrier, A. Michaud, P. Corvol and E. Clauser (1991) Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J. Biol. Chem. 266 5540-5546.
143. L. Wei, E. Clauser, F. Alhenc-Gelas and P. Corvol (1992) The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267 13398-13405.
144. T.A. Williams, N.M. Hooper and A.J. Turner (1991) Characterization of neuronal and endothelial forms of angiotensin converting enzyme in pig brain. J. Neurochem. 57 193-199.
145. T.A. Williams, K. Barnes, A.J. Kenny, A.J. Turner and N.M. Hooper (1992) A comparison of the zinc content and substrate specificity of the endothelial and testicular forms of porcine angiotensin converting enzyme, and the isolation of isoenzyme specific antisera. Biochem. J. 288 878-881.
146. T.A. Williams, P. Corvol and F. Soubrier (1994) Identification of two active site residues in human angiotensin I-converting enzyme. J. Biol. Chem. 269 29430-29434.
147. Z.L. Woodman, S.Y. Oppong, S. Cook, N.M. Hooper, S.L. Schwager, W.F. Brandt, M.R. Ehlers and E.D. Sturrock (2000) Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites. Biochem. J. 347 711-718.
148. J. Xavier-Neto, A.C. Pereira, M.L. Junqueira, R. Carmona and J.E. Krieger (1999) Rat angiotensin-converting enzyme promoter regulation by β-adrenergics and cAMP in endothelium. Hypertension 34 31-38.
149. H.Y.T. Yang, E.G. Erdös and Y. Levin (1970) A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta 214 374-376.
150. T. Yasui, F. Alhenc-Gelas, P. Corvol and J. Menard (1984) Angiotensin I-converting enzyme in amniotic fluid. J. Lab. Clin. Med. 104 741-751.
151. H. Yokosawa, S. Endo, Y. Ogura and S. Ishii (1983) A new feature of angiotensin-converting enzyme in the brain: hydrolysis of substance P. Biochem. Biophys. Res. Commun. 116 735-742.
152. H. Zhang, J. Wada, K. Hida, Y. Tsuchiyama, K. Hiragushi, K. Shikata, H. Wang, S. Lin, Y.S. Kanwar and H. Makino (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 276 17132-17139.
153. Y. Zhou, Z. Sun, A.R. Means, P. Sassone-Corsi and K.E. Bernstein (1996) cAMP-response element modulator τ is a positive regulator of testis angiotensin converting enzyme transcription. Proc. Natl. Acad. Sci. USA 93 12262-12266.